dc.contributor | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor | Universidade Federal do Rio de Janeiro (UFRJ) | |
dc.creator | Lemos, Lara B. | |
dc.creator | Perez, Renata M. | |
dc.creator | Lemos, Marcelo M. | |
dc.creator | Lanzoni, Valeria P. | |
dc.creator | Draibe, Sergio A. | |
dc.creator | Souza e Silva, Ivonete Sandra de [UNIFESP] | |
dc.creator | Silva, Antonio Eduardo B. | |
dc.creator | Ferraz, Maria Lucia G. | |
dc.date.accessioned | 2016-01-24T12:41:48Z | |
dc.date.accessioned | 2022-10-07T20:43:44Z | |
dc.date.available | 2016-01-24T12:41:48Z | |
dc.date.available | 2022-10-07T20:43:44Z | |
dc.date.created | 2016-01-24T12:41:48Z | |
dc.date.issued | 2007-01-01 | |
dc.identifier | American Journal of Nephrology. Basel: Karger, v. 27, n. 2, p. 191-196, 2007. | |
dc.identifier | 0250-8095 | |
dc.identifier | http://repositorio.unifesp.br/handle/11600/29438 | |
dc.identifier | 10.1159/000100892 | |
dc.identifier | WOS:000245138400012 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/4021940 | |
dc.description.abstract | Background: the characteristics of hepatitis C virus (HCV) infection in predialysis patients are poorly understood and they could be different from hemodialysis patients. Aims: To evaluate the demographics, laboratory and histological characteristics of chronic HCV infection in predialysis patients and to compare them with those observed in hemodialysis patients. Methods: Thirty-nine predialysis patients with chronic HCV infection were compared to HCV-infected hemodialysis patients (ratio of 1: 3) in terms of demographics, laboratory and histological characteristics. the fibrosis progression rate (FPR) was calculated as the ratio between fibrosis stage and duration of infection. Results: Predialysis patients were older (57 8 10 vs. 45 8 12 years; p < 0.001), presented a higher proportion of elevated alanine aminotransferase (71.8 vs. 41.0%; p = 0.001) and aspartate aminotransferase (64.1 vs. 26.5%; p < 0.001), a higher proportion of interface hepatitis (66.7 vs. 47%; p = 0.033) and more advanced fibrosis (71.8 vs. 16.2%; p = 0.001). Among patients with estimated duration of infection, predialysis patients presented a longer duration of infection (22 vs. 6 years; p < 0.001) and no difference in FPR was observed between groups (p = 0.692). Conclusion: Although predialysis patients with HCV infection present more severe histological injury than hemodialysis patients, this finding probably reflects a longer duration of infection with no evidence supporting that hepatitis C presents a more aggressive course in this group. Copyright (c) 2007 S. Karger AG, Basel | |
dc.language | eng | |
dc.publisher | Karger | |
dc.relation | American Journal of Nephrology | |
dc.rights | http://www.karger.com/Services/RightsPermissions | |
dc.rights | Acesso restrito | |
dc.subject | hepatitis C virus | |
dc.subject | chronic kidney disease | |
dc.subject | fibrosis | |
dc.subject | hemodialysis | |
dc.subject | alanine aminotransferase | |
dc.title | Hepatitis C in chronic kidney disease: Predialysis patients present more severe histological liver injury than hemodialysis patients? | |
dc.type | Artigo | |